These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11098057

  • 1. Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitope.
    David M, Borza DB, Leinonen A, Belmont JM, Hudson BG.
    J Biol Chem; 2001 Mar 02; 276(9):6370-7. PubMed ID: 11098057
    [Abstract] [Full Text] [Related]

  • 2. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain.
    Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, Hudson BG.
    J Biol Chem; 2000 Feb 25; 275(8):6030-7. PubMed ID: 10681598
    [Abstract] [Full Text] [Related]

  • 3. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain.
    Netzer KO, Leinonen A, Boutaud A, Borza DB, Todd P, Gunwar S, Langeveld JP, Hudson BG.
    J Biol Chem; 1999 Apr 16; 274(16):11267-74. PubMed ID: 10196215
    [Abstract] [Full Text] [Related]

  • 4. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
    Kalluri R, Sun MJ, Hudson BG, Neilson EG.
    J Biol Chem; 1996 Apr 12; 271(15):9062-8. PubMed ID: 8621555
    [Abstract] [Full Text] [Related]

  • 5. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.
    Leinonen A, Netzer KO, Boutaud A, Gunwar S, Hudson BG.
    Kidney Int; 1999 Mar 12; 55(3):926-35. PubMed ID: 10027929
    [Abstract] [Full Text] [Related]

  • 6. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
    Borza DB, Hudson BG.
    Springer Semin Immunopathol; 2003 May 12; 24(4):345-61. PubMed ID: 12778332
    [Abstract] [Full Text] [Related]

  • 7. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains.
    Borza DB, Bondar O, Todd P, Sundaramoorthy M, Sado Y, Ninomiya Y, Hudson BG.
    J Biol Chem; 2002 Oct 18; 277(42):40075-83. PubMed ID: 12193605
    [Abstract] [Full Text] [Related]

  • 8. Alveolar basement membrane: molecular properties of the noncollagenous domain (hexamer) of collagen IV and its reactivity with Goodpasture autoantibodies.
    Gunwar S, Bejarano PA, Kalluri R, Langeveld JP, Wisdom BJ, Noelken ME, Hudson BG.
    Am J Respir Cell Mol Biol; 1991 Aug 18; 5(2):107-12. PubMed ID: 1892641
    [Abstract] [Full Text] [Related]

  • 9. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen.
    Neilson EG, Kalluri R, Sun MJ, Gunwar S, Danoff T, Mariyama M, Myers JC, Reeders ST, Hudson BG.
    J Biol Chem; 1993 Apr 25; 268(12):8402-5. PubMed ID: 8473281
    [Abstract] [Full Text] [Related]

  • 10. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
    Ryan JJ, Mason PJ, Pusey CD, Turner N.
    Clin Exp Immunol; 1998 Jul 25; 113(1):17-27. PubMed ID: 9697978
    [Abstract] [Full Text] [Related]

  • 11. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease.
    Hellmark T, Segelmark M, Unger C, Burkhardt H, Saus J, Wieslander J.
    Kidney Int; 1999 Mar 25; 55(3):936-44. PubMed ID: 10027930
    [Abstract] [Full Text] [Related]

  • 12. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.
    Hellmark T, Burkhardt H, Wieslander J.
    J Biol Chem; 1999 Sep 03; 274(36):25862-8. PubMed ID: 10464328
    [Abstract] [Full Text] [Related]

  • 13. Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.
    MacDonald BA, Sund M, Grant MA, Pfaff KL, Holthaus K, Zon LI, Kalluri R.
    Blood; 2006 Mar 01; 107(5):1908-15. PubMed ID: 16254142
    [Abstract] [Full Text] [Related]

  • 14. A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes.
    Vanacore RM, Ham AJ, Cartailler JP, Sundaramoorthy M, Todd P, Pedchenko V, Sado Y, Borza DB, Hudson BG.
    J Biol Chem; 2008 Aug 15; 283(33):22737-48. PubMed ID: 18499662
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
    Cui Z, Zhao MH, Jia XY, Wang M, Hu SY, Wang SX, Yu F, Brown KL, Hudson BG, Pedchenko V.
    J Autoimmun; 2016 Jun 15; 70():1-11. PubMed ID: 27117167
    [Abstract] [Full Text] [Related]

  • 16. Glomerular basement membrane. Identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen.
    Gunwar S, Ballester F, Kalluri R, Timoneda J, Chonko AM, Edwards SJ, Noelken ME, Hudson BG.
    J Biol Chem; 1991 Aug 15; 266(23):15318-24. PubMed ID: 1869555
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Precise mapping of the Goodpasture epitope(s) using phage display, site-directed mutagenesis, and surface plasmon resonance.
    Gozalbo-Rovira R, Rodríguez-Díaz J, Saus J, Cervera J.
    Kidney Int; 2013 Mar 15; 83(3):438-45. PubMed ID: 23254898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.